The Global Therapeutic Drugs Market would grow with a CAGR value of 7.00% and will generate USD 2.10 billion by 2026. The therapeutic drug monitoring (TDM) will register high growth between 2021-2026 due to the growing demand for better healthcare among urban population. Increased knowledge of drug pharmacogenetics and pharmacokinetics inclines clinicians to monitor certain medications for therapeutic drugs (TDM)
https://www.globalmarketestimates.com/market-report/global-therapeutic-drug-monitoring-market-2804
By
Product (Consumables, Equipment), By Technology (Immunoassays &
Chromatography-MS) By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs,
Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs, Psychoactive
Drugs, and Other Drug Classes) By End- User (Hospital Laboratories,
Commercial/Private Laboratories, Other End Users) By Region (North America,
Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market
Share Analysis & Competitor Analysis.
Key Market Insights:
·
The consumable segment is will be the
prominent and segment and occupying maximum share in the global market.
·
The
immunoassay category holds the highest share in the technology segment. Also,
immunoassays are simple to carry out and do not need advanced training.
·
F. Hoffmann-La Roche (Switzerland), UTAK
(U.S.), Siemens Healthineers (Germany), Grifols (Spain), BÜHLMANN Laboratories
(Switzerland), Abbott Laboratories, apDia Group, BioTeZ Berlin-Buch GmbH,
Thermo Fisher Scientific, R-Biopharm AG, Bio-Rad Laboratories, Exagen Inc.,
bioMérieux (France), Danaher Corporation, Aalto Scientific (U.S.),
Immundiagnostik AG, Cambridge Life Sciences Limited, Chromsystems Instruments
& Chemicals GmbH, DiaSystem Scandinavia AB (Sweden), SEKISUI MEDICAL
(Japan), ARK Diagnostics, Inc. (U.S.), and Randox Laboratories (Ireland) are
the key palyers involved in developing Therapeutic Drug Monitoring systems.
·
Abbott released a new test in April 2020
that will show whether you've ever had the coronavirus, with the aim to pump
millions out.
Browse
the Report @ https://www.globalmarketestimates.com/market-report/global-therapeutic-drug-monitoring-market-2804
Product Outlook
(Revenue, USD Million, 2021-2026)
·
Consumables
·
Equipment
·
Immunoassay
Analyzers
·
Chromatography
& MS Detectors
·
Clinical
Chemistry Analyzers
Technology
Outlook (Revenue, USD Million, 2021-2026)
·
Immunoassays
·
Chemiluminescent
Immunoassays
·
Fluorescence
Immunoassays
·
Calorimetric
Immunoassays
·
Radioimmunoassays
·
Other
Immunoassays
·
Chromatography-MS
·
Liquid
Chromatography/Mass Spectrometry (LC-MS)
·
Gas
Chromatography-Mass Spectrometry (GC-MS)
Class of Drug Outlook (Revenue, USD
Million, 2021-2026)
·
Antiepileptic
Drugs
·
Antiarrhythmic Drugs
·
Immunosuppressant Drugs
·
Antibiotic Drugs
·
Bronchodilator Drugs
·
Psychoactive Drugs
·
Other Drug Classes
End-User Outlook
(Revenue, USD Million, 2021-2026)
|
·
Hospital
Laboratories |
||
|
·
Commercial/Private
Laboratories |
||
|
·
Other End
Users |
||
Region Outlook
(Revenue, USD Million, 2021-2026)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central
& South America
- Brazil
- Argentina
- Rest
of CSA
Middle
East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Tracy Simon
Email
address: tracy.simon@globalmarketestimates.com
Phone
Number: +16026667238
Website:
https://www.globalmarketestimates.com/
No comments:
Post a Comment